About Us

Chief Medical Officer, Digital Care Transformation, Mass General Brigham; Associate Professor of Medicine, Harvard Medical School; Associate Physician, Brigham and Women's Hospital; Senior Investigator, TIMI Study Group, Brigham and Women's Hospital

Dr. Benjamin Scirica is a cardiologist and clinical researcher at Brigham and Women's Hospital where he is Director of Innovation in the Cardiovascular Medicine and Senior Investigator at the TIMI Study Group.

Ben is Associate Professor of Medicine at Harvard Medical School. His clinical focus is on the identification and application of novel therapeutic strategies across the spectrum of cardiometabolic diseases and testing the optimal methods to implement guideline-directed care.

Education Director, Digital Care Transformation, Mass General Brigham; Professor of Medicine, Harvard Medical School; Senior Physician, Brigham and Women's Hospital

Dr. Cannon is a Professor of Medicine at Harvard Medical School and senior physician in the Cardiovascular Division at Brigham and Women's Hospital. He currently serves as Education Director in the Cardiovascular Innovation group where he helped developed a patient education web portal with micro-learning videos on the disease area and therapies used in the Remote Health program. He also oversees medical education and training of the patient navigators and staff.

Dr. Cannon has worked for 25 years as an investigator in the TIMI Study Group, then for 5 years with the Harvard Clinical Research Institute (now Baim Institute). He has been principal investigator of more than 20 multicenter clinical trials, including TACTICS-TIMI 18, PROVE IT, IMPROVE IT, RE-DUAL PCI and VERTIS CV trials. Dr. Cannon has published over 1000 original articles, reviews, book chapters or books in the field of acute coronary syndromes, atrial fibrillation, diabetes, lipids and prevention.

Director of Operations, Digital Care Transformation, Mass General Brigham

Mr. Oates joined Partners in 2012 and helped commercialize the GeneInsight genetics software suite, with an acquisition by Sunquest (NYSE:ROP). He has over 30 years of technology leadership experience. An early employee (3rd) of Sapient (NASD: SAPE), he served as Vice President of Technology responsible for helping Fortune 500 companies achieve business value through the innovative use of technology. He established core capabilities within Sapient to manage project risk, technology reuse, and dissemination of best practices aimed at fueling rapid company growth. Prior to joining Sapient, Mr. Oates worked at Cambridge Technology Partners (NASD: NOVL) and attended Cornell University.

Associate Professor of Medicine, Harvard Medical School; Director of Health Economic Evaluations, Cardiovascular Innovation, Brigham and Women's Hospital

Thomas A. Gaziano M.D., M.Sc. is an Associate Professor of Medicine at Harvard Medical School in the Division of Cardiovascular Medicine at Brigham and Women's Hospital (BWH). He is Director of Economic Evaluations within Cardiovascular Innovations at BWH where he evaluates innovative prevention programs in clinical services. He is currently a principal or co-principal investigator on three NIH-funded grants in Argentina and South Africa, the main focus of which are the implementation of effective cardiovascular therapies or policies in low-income settings. His CVD PREDICT model is used to evaluate health outcomes, financial impacts, and the cost-effectiveness of CVD intervention strategies.

Director, Preventative Cardiology, Division of Cardiovascular Medicine, Brigham and Women's Hospital

Jorge Plutzky, M.D., is the Director of Preventive Cardiology at Brigham and Women's Hospital (BWH) and a widely recognized authority on preventive cardiology. He directs the BWH Lipid/Prevention Clinic — a high volume referral center for patients with complex lipid, cholesterol and atherosclerotic disorders. Dr. Plutzky is actively involved in translational research projects that integrate closely with his NIH-funded basic science laboratory.

Dr. Plutzky, the current chair of the American Heart Association's Diabetes Committee, received his B.A. With Highest Distinction (Echol's Scholar) from the University of Virginia and his M.D. from the University of North Carolina. He completed medical residency and cardiology fellowship at Brigham and Women's Hospital and research fellowships at NIH and MIT.

Director of Solution and Experience, Digital Care Transformation, Mass General Brigham; Instructor of Medicine, Harvard Medical School

William Gordon, MD, MBI is an internist and clinical informaticist at Brigham and Women's Hospital and Mass General Brigham in Boston, Massachusetts. Dr. Gordon has spent more than a decade working in healthcare information technology, and has written extensively on information security, interoperability, data standards, and digital product development. He is currently faculty in the Division of General Internal Medicine and Primary Care at Brigham and Women's Hospital, the Department of Biomedical Informatics at Harvard Medical School, and he is the Director of Solution and Experience for Digital Care Transformation at Mass General Brigham.

William is also an attending physician in the hospital medicine unit at Brigham and Women's Hospital and an Instructor in Medicine at Harvard Medical School.

Sr. Director of Information Technology, Digital Care Transformation; Executive Director of Information Technology, Personalized Medicine; Associate Director, Research Information Sciences and Computing

Mr. Aronson's team is focused on using technology to improve clinical processes. We partner with clinical leaders to leverage business process engineering and enterprise application development capabilities to fundamentally redesign clinical workflows to reduce cost and improve outcomes. Mr. Aronson was one of the founders of GeneInsight. He also previously held several positions with Sapient Corporation, was a Monitor Company consultant and founded both LearningAction and Stanford Data Solutions.

Mr. Aronson holds a Masters in Organizational Behavior and a Bachelors in Computer Science from Stanford University. He also received a Masters in Biology from Harvard Extension School.

Director of Hypertension, Remote CV Health; Director, Hypertension Specialty Clinic; Division of Endocrinology, Diabetes and Hypertension; Associate Professor of Medicine, Harvard Medical School

Dr. Naomi Fisher directs our hypertension program. She is an endocrinologist widely recognized for her work dedicated to evaluating and treating high blood pressure. Dr. Fisher directs the Hypertension Specialty Clinic at the Brigham and Women's Hospital, and also has a longstanding clinical research career at Harvard University. Her bibliography includes original scientific reports in high impact medical journals, as well as standards of care, clinical guidelines, reviews and online resources. She is a veteran teacher, directing and lecturing in several medical education courses, and is invited regularly to teach house staff, fellows, primary care doctors and specialists about hypertension.

Principal Architect, Health Innovation Platform, Mass General Brigham

Mr. Clark has over 17 years of experience building and architecting clinical applications that enable new forms of care delivery. Before its acquisition by Sunquest Information Systems, Eugene led design and development of GeneInsight at Partners HealthCare, architecting the software as a continuous learning system. Post-acquisition, Eugene led the software architecture program for all product lines at Sunquest Information Systems, working with product, infrastructure and customer teams. Within Digital Care Transformation, Eugene oversees the development team and drives architecture for the Health Innovation Platform and new CRM based clinical programs. Eugene holds a Bachelor of Music degree in Jazz Studies.

Director, Business Development, Mass General Brigham

Mike works in Business Development at Mass General Brigham, where he focuses on supporting the commercialization of digital health, collaboration with industry, and exploration of potential digital and artificial intelligence investments for the Artificial Intelligence Digital Venture Fund (AIDIF). Before joining MGB Innovation, Mike spent ten years in Mass General Brigham Corporate Business Planning, where he held the split role of Senior Executive Director of Business Transformation and Corporate Director of Business Planning.

At MGB, he has led large system-wide strategic initiatives across MGB, including exploration of new business opportunities, operational and financial improvement of key hospitals and their assets, mergers and acquisitions, physician and hospital network development, joint venture and partnership opportunities, the development of innovative clinical offerings, and large capital projects. Mike holds a B.A. from the College of the Holy Cross and an M.B.A from Boston College.